Perspective Therapeutics (CATX) Long-Term Investments (2014 - 2016)

Perspective Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $3.0 million for Q2 2016.

• In Q2 2016, Long-Term Investments fell 41.78% year-over-year to $3.0 million; the TTM figure through Jun 2016 stood at $3.0 million (down 41.78% YoY), while the FY2016 annual figure was $3.0 million, down 41.78% from the prior year.
• Long-Term Investments came in at $3.0 million for Q2 2016 at Perspective Therapeutics, down from $5.2 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q2 2014 to a low of $3.0 million in Q2 2016.
• A 3-year average of $4.8 million and a median of $5.2 million in 2015 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments declined 5.45% in 2015 and plunged 41.78% in 2016, its largest moves.
• Perspective Therapeutics' Long-Term Investments stood at $5.4 million in 2014, then fell by 4.4% to $5.2 million in 2015, then sank by 42.42% to $3.0 million in 2016.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.0 million, $5.2 million, and $5.2 million for Q2 2016, Q1 2016, and Q4 2015 respectively.

Peer Comparison